GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?
about
Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer riskClinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
P2860
GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@en
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@nl
type
label
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@en
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@nl
prefLabel
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@en
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@nl
P2093
P2860
P356
P1476
GSTM1 null genotype in COPD an ...... odifier or confounding effect?
@en
P2093
Bryan A Hay
Gregory D Gamble
Robert P Young
P2860
P304
P356
10.2147/TACG.S21517
P577
2011-09-13T00:00:00Z